TY  - JOUR
AU  - Gallardo, Fernando
AU  - Regueiro González-Barros, José Ramón
AU  - Espinosa, Lluís
PY  - 2022
DO  - 10.1182/bloodadvances.2021006860
UR  - https://hdl.handle.net/20.500.14352/107401
T2  - Blood Advances
AB  - Current therapeutic approaches for Sézary syndrome (SS) do not achieve a significant improvement in long-term survival of patients, and they are mainly focused on reducing blood tumor burden to improve quality of life. Eradication of SS is hindered by...
LA  - eng
M2  - 3410
PB  - American Society of Hematology
TI  - Sézary syndrome patient–derived models allow drug selection for personalized therapy
TY  - journal article
VL  - 6
ER  -